Invitation to Roche’s Diagnostics Day 2025 Dienstag, 15. April 2025 - 14:04

Investor Update

Invitation to Roche's Diagnostics Day 2025

The Roche Investor Relations team would like to invite you to the Roche Diagnostics Day taking place in London on Tuesday, 27 May 2025, starting at 12:00 BST local time and finishing at 15:45 BST, followed by refreshments with the Roche Management Team.

The Roche Diagnostics Day will address the following topics:

Roche SBX Sequencing solution
Roche Mass Spectrometry update
Molecular Lab upcoming launches
Pathology Lab upcoming launches
Near Patient Care upcoming launches
Core Lab upcoming launches

Presenters include:

Matt Sause, CEO Roche Diagnostics
Palani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS)
Moritz Hartmann, Global Head of Roche Information Solutions
Josh Lauer, Head of Molecular Customer Labs Area
Jill German, Head of Roche Pathology Customer Labs Area
Ildiko Amann-Zalan, Head of Research & Development Roche Diagnostics Solutions
Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems
Olivier Gillieron, Lifecycle Leader Cardiometabolic and Neurology

Meeting information:
Date/Time (BST):
Tuesday, 27 May 2025
12:00 - 13:00 Registration and lunch
13:00 - 15:45 Presentations & Q&A
15:45 - 16:15 Refreshments with Roche Management Team

Venue
Pan Pacific London
80 Houndsditch
London EC3A 7AB
> map

To register for the event, please follow this > link (passcode: Dia2025).

The slides will be available for download at 12:00 BST on the day of the event.
> click here

Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

A replay of the event will be available via > roche.com/investors

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Birgit Masjost
Investor Relations Officer/Leader Diagnostics

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com